[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 31 of about 31
1. Kovalenko S, Lukashenko P, Romanovskaya A, Soldatski IL, Bakanov SI, Pfister H, Gerein V: Distribution and density of CD1a+ and CD83+ dendritic cells in HPV-associated laryngeal papillomas. Int J Pediatr Otorhinolaryngol; 2009 Feb;73(2):249-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Respiratory papillomatosis associated with human papilloma virus (HPV) infection is the most common benign laryngeal neoplasm.
  • [MeSH-major] Antigens, CD / analysis. Antigens, CD1 / analysis. Dendritic Cells / virology. Immunoglobulins / analysis. Laryngeal Neoplasms / virology. Membrane Glycoproteins / analysis. Papilloma / virology
  • [MeSH-minor] Adolescent. Cell Count. Child. Child, Preschool. Female. Human papillomavirus 11 / immunology. Human papillomavirus 6 / immunology. Humans. Infant. Larynx / cytology. Larynx / virology. Male. Papillomavirus Infections / metabolism. Papillomavirus Infections / pathology. Papillomavirus Infections / virology. Retrospective Studies. Tissue Distribution. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19062106.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD1; 0 / CD1a antigen; 0 / CD83 antigen; 0 / Immunoglobulins; 0 / Membrane Glycoproteins
  •  go-up   go-down


2. Xiao P, Zhang XS: Adult laryngotracheal surgery. Anesthesiol Clin; 2010 Sep;28(3):529-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The human larynx plays a pivotal role in airway protection, respiration, and phonation.
  • Laryngeal disorders can be divided into two categories, benign lesions and malignant lesions.
  • Most benign lesions are treatable with surgery and speech therapy, whereas the malignant lesions require more invasive surgery as well as radiation and chemotherapy.
  • [MeSH-major] Anesthesia. Larynx / surgery. Trachea / surgery
  • [MeSH-minor] Adult. Anesthesia, General. Humans. Laryngeal Diseases / surgery. Laryngeal Neoplasms / diagnosis. Laryngeal Neoplasms / epidemiology. Laryngeal Neoplasms / pathology. Laryngeal Neoplasms / surgery. Laryngectomy. Papilloma / surgery. Preoperative Care. Reconstructive Surgical Procedures. Tracheitis / surgery

  • MedlinePlus Health Information. consumer health - Anesthesia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20850083.001).
  • [ISSN] 1932-2275
  • [Journal-full-title] Anesthesiology clinics
  • [ISO-abbreviation] Anesthesiol Clin
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


3. Lau DP, Huang Z, Lui H, Anderson DW, Berean K, Morrison MD, Shen L, Zeng H: Raman spectroscopy for optical diagnosis in the larynx: preliminary findings. Lasers Surg Med; 2005 Sep;37(3):192-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Raman spectroscopy for optical diagnosis in the larynx: preliminary findings.
  • To determine if Raman spectra could be obtained rapidly from laryngeal tissue in vitro, and compare Raman spectra from normal, benign, and cancerous laryngeal tissue.
  • Multivariate analysis was used to determine the diagnostic ability of RS compared to standard histology (n = 18, 13, and 16 respectively for normal tissue, carcinoma, and squamous papilloma).
  • Spectral peak analysis showed prediction sensitivities of 89%, 69%, and 88%, and specificities of 86%, 94%, and 94% for normal tissue, carcinoma, and papilloma.
  • CONCLUSIONS: In the larynx, spectral differences appear to exist between normal tissue, carcinoma, and papilloma.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Laryngeal Neoplasms / diagnosis. Papilloma / diagnosis. Spectrum Analysis / methods

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 16127671.001).
  • [ISSN] 0196-8092
  • [Journal-full-title] Lasers in surgery and medicine
  • [ISO-abbreviation] Lasers Surg Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Wemer RD, Lee JH, Hoffman HT, Robinson RA, Smith RJ: Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol; 2005 Nov;114(11):836-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent respiratory papillomatosis (RRP) is characterized by benign wartlike growths in the larynx with occasional spread to the lungs.
  • The initial pathology results demonstrated benign disease with progression to severe dysplasia during the treatment time.
  • [MeSH-major] Laryngeal Neoplasms / drug therapy. Laryngeal Neoplasms / pathology. Papilloma / drug therapy. Papilloma / pathology

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIDOFOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ann Otol Rhinol Laryngol. 2005 Nov;114(11):834-5 [16358602.001]
  • (PMID = 16358603.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organophosphonates; 8J337D1HZY / Cytosine; JIL713Q00N / cidofovir
  •  go-up   go-down


5. Pawlita M, Gissmann L: [Recurrent respiratory papillomatosis: indication for HPV vaccination?]. Dtsch Med Wochenschr; 2009 Apr;134 Suppl 2:S100-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is characterized by proliferation of benign squamous cell papillomas within the respiratory-digestive tract, predominantly the larynx.
  • RRP is caused by oral infection with human papilloma virus (HPV) types 6 or 11.
  • Here we propose the hypothesis that HPV vaccination could have a therapeutic effect in RRP by preventing new papilloma formation at additional sites.

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19353471.001).
  • [ISSN] 1439-4413
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; 0 / Papillomavirus Vaccines
  •  go-up   go-down


6. Gerein V, Soldatski IL, Babkina N, Onufrieva EK, Barysik N, Pfister H: Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation. Int J Pediatr Otorhinolaryngol; 2006 Dec;70(12):2061-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm affecting the larynx and upper respiratory tract.
  • [MeSH-major] Neoplasm Recurrence, Local / pathology. Papilloma / pathology. Pregnancy Complications, Neoplastic / pathology. Respiratory Tract Neoplasms / pathology. Sexual Partners

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16945430.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Ireland
  •  go-up   go-down


7. Szyfter W, Wierzbicka M, Jackowska J, Bartochowska A, Banaszewski J: [The schedule of intralesional papillomatosis treatment with cidofovir]. Otolaryngol Pol; 2010 Mar-Apr;64(2):98-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is characterized by proliferation of benign squamous cell papillomas within the respiratory-digestive tract, predominantly the larynx.
  • CONCLUSIONS: Intralesional cidofovir injection has been shown to be an effective an safe therapy for laryngeal papilloma and should be considered in those patients who experienced disease relapse.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Cytosine / analogs & derivatives. Laryngeal Neoplasms / drug therapy. Neoplasm Recurrence, Local / drug therapy. Organophosphonates / administration & dosage. Papilloma / drug therapy. Respiratory Tract Neoplasms / drug therapy

  • Hazardous Substances Data Bank. CIDOFOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20568538.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organophosphonates; 8J337D1HZY / Cytosine; JIL713Q00N / cidofovir
  •  go-up   go-down


8. Martins RH, Dias NH, Gregório EA, Marques MA, Silva MG, Candeias JM: Laryngeal papillomatosis: morphological study by light and electron microscopy of the HPV-6. Braz J Otorhinolaryngol; 2008 Jul-Aug;74(4):539-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Laryngeal papillomatosis is the most frequent benign neoplasia in children.
  • The lesions are exophytic and highly recurrent, compromising the airway mucosa, mainly the larynx.
  • [MeSH-major] Human papillomavirus 6 / ultrastructure. Laryngeal Neoplasms / virology. Papilloma / virology. Papillomavirus Infections / virology

  • Genetic Alliance. consumer health - Laryngeal papillomatosis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18852979.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


9. Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C, Selman M, Gariglio P: Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res; 2006 Dec 1;12(23):6946-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: The mechanism of larynx oncogenesis is complex and controlled by various factors, most of them involved in cell proliferation and apoptosis.
  • Normal larynx samples and those from laryngeal papillomatosis exhibited similar relatively high numbers of apoptotic cells, whereas in malignant tumors, these cells were scarce.
  • CONCLUSION: Our results suggest that HPV is an important risk factor in papillomatosis and in some malignant larynx tumors with a strong participation of cellular genes, specifically involved in proliferation and apoptosis.
  • In benign papillomatosis lesions but not in larynx cancer, high p53 activity might preserve the apoptosis process.
  • In larynx cancer, low p53 levels and high bcl-2 expression may be playing an important role to block apoptosis.
  • [MeSH-major] Laryngeal Neoplasms / genetics. Papilloma / genetics. Papillomaviridae / isolation & purification. Proto-Oncogene Proteins c-bcl-2 / genetics. Proto-Oncogene Proteins c-myc / genetics. Retinoblastoma Protein / genetics. Tumor Suppressor Protein p53 / genetics

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17145812.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Proto-Oncogene Proteins c-myc; 0 / Retinoblastoma Protein; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


10. Fischer M: Investigation of a broad-spectrum PCR assay for human papillomaviruses in screening benign lesions of the upper aerodigestive tract. ORL J Otorhinolaryngol Relat Spec; 2005;67(4):237-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Investigation of a broad-spectrum PCR assay for human papillomaviruses in screening benign lesions of the upper aerodigestive tract.
  • BACKGROUND: A variety of different human papillomavirus (HPV) types can be found in benign and malignant lesions of the upper aerodigestive tract.
  • RESULTS: A total of 27 biopsies from laryngeal papillomas (9), exophytic (3) and inverted (6) papillomas of the nasal cavity or paranasal sinuses, papillomas of the uvula or soft palate (5), leukoplakias of the larynx (2), seborrheic keratosis (1) and granulation tumor of the tongue (1) were analyzed by the broad-spectrum PCR system.
  • CONCLUSIONS: It was shown that the applied broad-spectrum PCR system is a reliable tool in the detection of HPV DNA in benign lesions of the upper aerodigestive tract.
  • [MeSH-minor] Consensus Sequence / genetics. DNA Primers. Genome, Viral / genetics. Granuloma / virology. Humans. Keratosis, Seborrheic / virology. Laryngeal Neoplasms / virology. Leukoplakia / virology. Nose Neoplasms / virology. Palatal Neoplasms / virology. Papilloma / virology. Papilloma, Inverted / virology. Papillomaviridae / classification. Papillomaviridae / genetics. Paranasal Sinus Neoplasms / virology. Sensitivity and Specificity. Tongue Diseases / virology. Uvula / virology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16276120.001).
  • [ISSN] 0301-1569
  • [Journal-full-title] ORL; journal for oto-rhino-laryngology and its related specialties
  • [ISO-abbreviation] ORL J. Otorhinolaryngol. Relat. Spec.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / DNA Primers
  •  go-up   go-down


11. Stamataki S, Nikolopoulos TP, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E: Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck; 2007 Feb;29(2):155-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Juvenile recurrent respiratory papillomatosis (RRP) is the most common benign neoplastic disease of the larynx in children and adolescents and has a significant impact on patients and the health care system with a cost ranging from $60,000 to $470,000 per patient.
  • [MeSH-major] Laryngeal Neoplasms / diagnosis. Laryngeal Neoplasms / therapy. Papilloma / diagnosis. Papilloma / therapy

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17022088.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunologic Factors; 0 / Interferon-alpha
  • [Number-of-references] 67
  •  go-up   go-down


12. Bielecki I, Mniszek J, Cofała M: Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol; 2009 May;73(5):681-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Papillomatosis of the larynx appears as the result of an infection by the human papilloma virus (HPV).
  • In children, the disease produces benign lesions, which grow rapidly and show a marked tendency to recur once removed.
  • The basic goal of treatment is to preserve the patency of air passages while simultaneously preserving the phonatory and anatomical functioning of the larynx.
  • Over the last 10 years, the possibility of a pharmacological treatment has been continually explored: in particular, the administration of locally passed cidofovir (first reported in a 1999 study by Pransky) to the larynx with papillomas is under current scrutiny.
  • GOAL OF STUDY: The goal of the following study is to estimate the effectiveness of locally administered cidofovir for treatment of papillomas of the larynx in children.
  • [MeSH-major] Antiviral Agents / therapeutic use. Cytosine / analogs & derivatives. Laryngeal Neoplasms / drug therapy. Organophosphonates / therapeutic use. Papilloma / drug therapy

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • Hazardous Substances Data Bank. CIDOFOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19193450.001).
  • [ISSN] 1872-8464
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Organophosphonates; 8J337D1HZY / Cytosine; JIL713Q00N / cidofovir
  •  go-up   go-down


13. Torrente MC, Ojeda JM: Exploring the relation between human papilloma virus and larynx cancer. Acta Otolaryngol; 2007 Sep;127(9):900-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exploring the relation between human papilloma virus and larynx cancer.
  • Human papilloma virus (HPV) has a role in benign and malignant pathology of the larynx.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17712666.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Papillomavirus Vaccines
  • [Number-of-references] 46
  •  go-up   go-down


14. Rad MH, Alizadeh E, Ilkhanizadeh B: Recurrent laryngeal papillomatosis with bronchopulmonary spread in a 70-year-old man. Tuberk Toraks; 2007;55(3):299-302
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent laryngeal papillomatosis (RRLP) which is characterized by wart like growths in the larynx is a rare benign disease seen in children and young adults and a few cases are reported in old aged adults.
  • [MeSH-major] Laryngeal Neoplasms / diagnosis. Lung Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Papilloma / diagnosis

  • Genetic Alliance. consumer health - Laryngeal papillomatosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17978930.001).
  • [ISSN] 0494-1373
  • [Journal-full-title] Tüberküloz ve toraks
  • [ISO-abbreviation] Tuberk Toraks
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


15. Gallagher TQ, Derkay CS: Recurrent respiratory papillomatosis: update 2008. Curr Opin Otolaryngol Head Neck Surg; 2008 Dec;16(6):536-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE OF REVIEW: Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm of the larynx in children.
  • RECENT FINDINGS: Recent investigations have resulted in the following findings: more accurate prevalence estimates of human papilloma virus in women in the United States; correlation of socioeconomic status and disease severity; the malignant potential of human papilloma virus in head and neck cancer; the role of the host immune system in RRP; the efficacy of a vaccine preventing human papilloma virus; the emergence of pulsed dye laser and potassium-titanyl-phosphate laser as a therapy for RRP; the efficacy of cidofovir as an adjunctive therapy for RRP; and the role of cyclooxygenase-2 in the molecular biology of RRP.
  • [MeSH-major] Alphapapillomavirus. Laryngeal Neoplasms / therapy. Papilloma / therapy


16. Derkay CS, Wiatrak B: Recurrent respiratory papillomatosis: a review. Laryngoscope; 2008 Jul;118(7):1236-47
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent respiratory papillomatosis (RRP), which is caused by human papillomavirus types 6 and 11, is the most common benign neoplasm of the larynx among children and the second most frequent cause of childhood hoarseness.
  • When surgical therapy is needed more frequently than four times in 12 months or there is evidence of RRP outside the larynx, adjuvant medical therapy should be considered.
  • Because RRP, although histologically benign, is so difficult to control and can cause severe morbidity and death, better therapies are needed.
  • The potential for a quadrivalent human papilloma vaccine is being explored to reduce the incidence of this disease.
  • [MeSH-major] Hoarseness / etiology. Laryngeal Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Papilloma / diagnosis. Respiratory Sounds / etiology
  • [MeSH-minor] Adult. Airway Obstruction / etiology. Child. Combined Modality Therapy. Humans. Laryngoscopy. Larynx / pathology. Larynx / surgery. Neoplasm Staging. Tumor Burden


17. Patel A, Rubin JS: The difficult airway: the use of subglottic jet ventilation for laryngeal surgery. Logoped Phoniatr Vocol; 2008;33(1):22-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The technique was used in a wide variety of surgical pathology, from benign hyperfunction-related laryngeal pathology, through paralytic vocal fold conditions, papilloma, granuloma, dysplasia and malignancy.
  • [MeSH-major] Airway Obstruction / prevention & control. Laryngeal Neoplasms / pathology. Laryngeal Neoplasms / surgery. Laryngoscopy / methods. Larynx / physiology. Otorhinolaryngologic Surgical Procedures / methods. Papilloma / pathology. Papilloma / surgery. Respiration, Artificial / methods

  • MedlinePlus Health Information. consumer health - Choking.
  • Hazardous Substances Data Bank. Carbon dioxide .
  • Hazardous Substances Data Bank. OXYGEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18344142.001).
  • [ISSN] 1401-5439
  • [Journal-full-title] Logopedics, phoniatrics, vocology
  • [ISO-abbreviation] Logoped Phoniatr Vocol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide; S88TT14065 / Oxygen
  •  go-up   go-down


18. Picciotti PM, Calò L, Mulè A, Maggiore C, Scarano E: Rhino sinusal bilateral hamartoma: a case report. Auris Nasus Larynx; 2008 Dec;35(4):569-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The hamartoma is a benign rare tumor constituted by a mixture of tissue.
  • Although hamartoma arising from the rhino sinusal region is very rare, head and neck surgeons must know this entity in order to differentiate it from inverted papilloma and adenocarcinoma.
  • Misinterpretation of this lesion may result in aggressive surgery for a benign lesion.

  • MedlinePlus Health Information. consumer health - Nose Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18207343.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


19. DeVoti JA, Rosenthal DW, Wu R, Abramson AL, Steinberg BM, Bonagura VR: Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med; 2008 Sep-Oct;14(9-10):608-17
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent respiratory papillomas (RRP) are benign airway tumors, caused primarily by human papillomaviruses (HPV) types 6 and 11.
  • Total ribonucleic acid (RNA) from 12 papillomas and 12 adjacent tissues were analyzed by microarray, and the matched sets of tissues compared by paired t test, to identify differentially expressed genes in papilloma tissues while minimizing variations intrinsic to individual patients.
  • The second group contained 37 genes that likely contribute to growth of papillomas as benign tumors, since the altered pattern of expression also had been reported previously in many cancers.
  • [MeSH-major] Gene Expression Profiling. Human papillomavirus 11 / pathogenicity. Human papillomavirus 6 / pathogenicity. Laryngeal Neoplasms. Oligonucleotide Array Sequence Analysis / methods. Papilloma
  • [MeSH-minor] Gene Expression Regulation. Humans. Laryngeal Mucosa / immunology. Laryngeal Mucosa / metabolism. Laryngeal Mucosa / pathology. Larynx / cytology. Larynx / immunology. Larynx / pathology. Larynx / virology. Proteins / genetics. Proteins / metabolism. Recurrence. Severity of Illness Index

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Infect Dis. 2004 Mar 1;189(5):871-9 [14976605.001]
  • [Cites] Eur J Surg Oncol. 2008 Apr;34(4):357-64 [17566693.001]
  • [Cites] Clin Diagn Lab Immunol. 2004 May;11(3):538-47 [15138179.001]
  • [Cites] Hum Immunol. 2004 Aug;65(8):773-82 [15336778.001]
  • [Cites] Proc Natl Acad Sci U S A. 1982 Sep;79(17):5425-9 [6291043.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 Jan;80(2):560-3 [6300854.001]
  • [Cites] Laryngoscope. 1987 Jun;97(6):678-85 [3035299.001]
  • [Cites] J Invest Dermatol. 1991 Oct;97(4):701-12 [1940442.001]
  • [Cites] Clin Diagn Lab Immunol. 1994 May;1(3):357-60 [7496977.001]
  • [Cites] J Urol. 1996 Jun;155(6):2105-12 [8618345.001]
  • [Cites] Cytokine. 2005 Mar 21;29(6):245-50 [15749024.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2005 Apr;114(4):289-95 [15895784.001]
  • [Cites] Cancer Res. 2005 Jul 1;65(13):5696-702 [15994944.001]
  • [Cites] J Immunol. 2005 Oct 15;175(8):4904-13 [16210592.001]
  • [Cites] Nature. 2006 May 11;441(7090):235-8 [16648838.001]
  • [Cites] Nature. 2006 Jul 27;442(7101):461-5 [16688182.001]
  • [Cites] Clin Immunol. 1999 Dec;93(3):302-11 [10600342.001]
  • [Cites] Clin Diagn Lab Immunol. 2000 Jan;7(1):79-85 [10618282.001]
  • [Cites] Cancer Res. 2000 Mar 1;60(5):1457-62 [10728713.001]
  • [Cites] Cancer Res. 2001 May 15;61(10):3869-76 [11358798.001]
  • [Cites] J Leukoc Biol. 2001 Jun;69(6):986-94 [11404386.001]
  • [Cites] J Leukoc Biol. 2001 Sep;70(3):357-66 [11527984.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2002 Nov;111(11):957-61 [12450166.001]
  • [Cites] J Neuroimmunol. 2003 Jun;139(1-2):36-43 [12799018.001]
  • [Cites] BMC Dermatol. 2003 Feb 24;3:1 [12600274.001]
  • [Cites] Virol J. 2006;3:75 [16961924.001]
  • [Cites] Immunogenetics. 2006 Oct;58(10):851-5 [17021861.001]
  • [Cites] J Leukoc Biol. 2007 Jan;81(1):28-37 [16943388.001]
  • [Cites] J Allergy Clin Immunol. 2007 Jan;119(1):106-14 [17208591.001]
  • [Cites] Laryngoscope. 2007 Feb;117(2):253-7 [17277618.001]
  • [Cites] Nat Med. 2007 Feb;13(2):139-45 [17290272.001]
  • [Cites] FASEB J. 2007 Apr;21(4):1026-36 [17227950.001]
  • [Cites] Nat Immunol. 2007 May;8(5):532-9 [17401367.001]
  • [Cites] Trends Immunol. 2007 May;28(5):207-12 [17395538.001]
  • [Cites] J Leukoc Biol. 2007 May;81(5):1258-68 [17307864.001]
  • [Cites] Cancer Gene Ther. 2007 Jun;14(6):523-32 [17384577.001]
  • [Cites] Mol Med. 2007 Mar-Apr;13(3-4):143-50 [17592548.001]
  • [Cites] Clin Exp Immunol. 2007 Aug;149(2):217-25 [17590166.001]
  • [Cites] J Med Chem. 2007 Aug 23;50(17):3984-4002 [17665889.001]
  • [Cites] Urology. 2007 Sep;70(3):602-7 [17688917.001]
  • [Cites] J Immunol. 2007 Nov 1;179(9):5897-906 [17947663.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17034-9 [17942669.001]
  • [Cites] J Immunol. 2007 Nov 15;179(10):6504-13 [17982039.001]
  • [Cites] Curr Opin Immunol. 2007 Dec;19(6):652-7 [17766098.001]
  • [Cites] J Biol Regul Homeost Agents. 2006 Jan-Jun;20(1-2):15-23 [18088550.001]
  • [Cites] J Biol Chem. 2004 Apr 2;279(14):13677-88 [14734551.001]
  • (PMID = 18607510.001).
  • [ISSN] 1528-3658
  • [Journal-full-title] Molecular medicine (Cambridge, Mass.)
  • [ISO-abbreviation] Mol. Med.
  • [Language] eng
  • [Grant] United States / NIDCR NIH HHS / DE / R01DE017227
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  • [Other-IDs] NLM/ PMC2442987
  •  go-up   go-down


20. Chitose S, Sakazaki T, Ono T, Kurita T, Mihashi H, Nakashima T: Immunological responses against human papilloma virus and human papilloma virus induced laryngeal cancer. J Laryngol Otol; 2010 Jun;124(6):659-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunological responses against human papilloma virus and human papilloma virus induced laryngeal cancer.
  • OBJECTIVE: This study aimed to clarify the local immune status in the larynx in the presence of infection or carcinogenesis associated with human papilloma virus.
  • METHODS: Cytological samples (for human papilloma virus detection) and laryngeal secretions (for immunoglobulin assessment) were obtained from 31 patients with laryngeal disease, during microscopic laryngeal surgery.
  • On histological examination, 12 patients had squamous cell carcinoma, four had laryngeal papilloma and 15 had other benign laryngeal disease.
  • Cytological samples were tested for human papilloma virus DNA using the Hybrid Capture 2 assay.
  • RESULTS: High risk human papilloma virus DNA was detected in 25 per cent of patients (three of 12) with laryngeal cancer.
  • Low risk human papilloma virus DNA was detected only in three laryngeal papilloma patients.
  • The mean laryngeal secretion concentrations of immunoglobulins M, G and A and secretory immunoglobulin A in human papilloma virus DNA positive patients were more than twice those in human papilloma virus DNA negative patients.
  • Patients with laryngeal cancer had higher laryngeal secretion concentrations of each immunoglobulin type, compared with patients with benign laryngeal disease.
  • The study assessed the mean laryngeal secretion concentrations of each immunoglobulin type in the 12 laryngeal cancer patients, comparing human papilloma virus DNA positive patients (n = 3) and human papilloma virus DNA negative patients (n = 9); the mean concentrations of immunoglobulins M, G and A and secretory immunoglobulin A tended to be greater in human papilloma virus DNA positive cancer patients, compared with human papilloma virus DNA negative cancer patients.
  • CONCLUSION: These results suggest that the local laryngeal immune response is activated by infection or carcinogenesis due to human papilloma virus.
  • The findings strongly suggest that secretory IgA has inhibitory activity against infection or carcinogenesis associated with human papilloma virus in the larynx.
  • [MeSH-major] Alphapapillomavirus / immunology. Carcinoma, Squamous Cell. Immunoglobulins / immunology. Laryngeal Neoplasms. Papilloma
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Humans. Laryngeal Diseases / immunology. Laryngeal Diseases / virology. Larynx / immunology. Larynx / virology. Male. Middle Aged. Young Adult

  • Genetic Alliance. consumer health - Laryngeal cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20370947.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Immunoglobulins
  •  go-up   go-down


21. Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z: Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol; 2006 Mar;70(3):469-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm affecting the larynx and upper respiratory tract in children.
  • [MeSH-major] Laryngeal Neoplasms / pathology. Laryngeal Neoplasms / virology. Papilloma / pathology. Papilloma / virology. Papillomaviridae / genetics. Papillomaviridae / isolation & purification

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16137771.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


22. Chaudhary AK, Singh M, Sundaram S, Mehrotra R: Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol; 2009;1:22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Other factors, including DNA viruses, especially human papilloma virus (HPV), may also play a role in the initiation or development of these lesions.
  • The prevalence of HPV in benign lesions as well as malignancies has been assessed by many techniques.
  • The role of HPV in etiopathogenesis, prevalence in benign and malignant lesions of this area and vaccination strategies are briefly reviewed here.

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Oncol. 2002 Sep;38(6):591-6 [12167437.001]
  • [Cites] J Virol Methods. 2002 Aug;105(1):159-70 [12176153.001]
  • [Cites] Indian J Dent Res. 2002 Apr-Jun;13(2):102-7 [12420576.001]
  • [Cites] Int J Oncol. 2002 Dec;21(6):1197-204 [12429968.001]
  • [Cites] Oral Oncol. 2003 Jan;39(1):37-48 [12457720.001]
  • [Cites] Proc AMIA Symp. 2002;:415-9 [12474876.001]
  • [Cites] N Engl J Med. 2002 Dec 19;347(25):1999-2009 [12490681.001]
  • [Cites] J Natl Cancer Inst. 2003 May 7;95(9):638-9 [12734307.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):594-600 [12738951.001]
  • [Cites] Med Microbiol Immunol. 2003 Aug;192(3):123-8 [12920585.001]
  • [Cites] Med Microbiol Immunol. 2003 Aug;192(3):145-8 [12920590.001]
  • [Cites] J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83 [14652239.001]
  • [Cites] Int J Cancer. 2004 Feb 20;108(5):766-72 [14696105.001]
  • [Cites] J Clin Virol. 2004 Aug;30(4):302-8 [15163418.001]
  • [Cites] Oral Oncol. 2004 Aug;40(7):736-41 [15172644.001]
  • [Cites] J Natl Cancer Inst. 2004 Jul 7;96(13):998-1006 [15240783.001]
  • [Cites] Crit Rev Oral Biol Med. 2004;15(4):188-96 [15284184.001]
  • [Cites] Carcinogenesis. 2004 Oct;25(10):1911-6 [15180941.001]
  • [Cites] Oral Oncol. 2008 Mar;44(3):242-50 [17467327.001]
  • [Cites] Cancer. 2008 Apr 25;114(2):118-23 [18300234.001]
  • [Cites] J Womens Health (Larchmt). 2008 May;17(4):539-48 [18370586.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2008 Jul;265 Suppl 1:S89-96 [18193443.001]
  • [Cites] Oral Oncol. 2008 Aug;44(8):812-5 [18061523.001]
  • [Cites] Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):263-5 [18712970.001]
  • [Cites] CMAJ. 2008 Sep 9;179(6):525-33 [18762618.001]
  • [Cites] Oral Oncol. 2008 Oct;44(10):915-9 [18329326.001]
  • [Cites] Ann Oncol. 2008 Oct;19(10):1681-90 [18558666.001]
  • [Cites] Mol Med. 2008 Sep-Oct;14(9-10):608-17 [18607510.001]
  • [Cites] Arch Pathol Lab Med. 2008 Oct;132(10):1653-6 [18834225.001]
  • [Cites] Braz J Otorhinolaryngol. 2008 Jul-Aug;74(4):539-43 [18852979.001]
  • [Cites] Laryngorhinootologie. 2008 Nov;87(11):796-9 [18759217.001]
  • [Cites] Carcinogenesis. 2008 Nov;29(11):2120-5 [18701437.001]
  • [Cites] Clin Cancer Res. 2008 Nov 1;14(21):7143-50 [18981014.001]
  • [Cites] Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):381-6 [18990006.001]
  • [Cites] Hematol Oncol Clin North Am. 2008 Dec;22(6):1125-42, vii [19010263.001]
  • [Cites] J Oral Pathol Med. 2008 Nov;37(10):593-8 [19012621.001]
  • [Cites] Cancer. 2008 Dec 15;113(12):3307-14 [18988287.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2009 Feb;73(2):249-56 [19062106.001]
  • [Cites] Epidemiol Prev. 2008 Jul-Oct;32(4-5):238-43 [19186506.001]
  • [Cites] J Natl Cancer Inst. 2000 May 3;92(9):690-8 [10793105.001]
  • [Cites] J Natl Cancer Inst. 2000 May 3;92(9):709-20 [10793107.001]
  • [Cites] Oral Oncol. 2000 May;36(3):256-63 [10793327.001]
  • [Cites] Mod Pathol. 2000 Jun;13(6):644-53 [10874669.001]
  • [Cites] Acta Otolaryngol. 2000 Oct;120(7):872-5 [11132723.001]
  • [Cites] Int J Cancer. 2001 Jul 15;93(2):232-5 [11410871.001]
  • [Cites] Cancer. 2001 Aug 15;92(4):805-13 [11550151.001]
  • [Cites] Head Neck. 2002 Feb;24(2):165-80 [11891947.001]
  • [Cites] Int J Oral Surg. 1983 Dec;12(6):418-24 [6325356.001]
  • [Cites] J Gen Virol. 1991 Jan;72 ( Pt 1):173-6 [1846646.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1991 Jun;71(6):714-20 [1648192.001]
  • [Cites] J Gen Virol. 1991 Nov;72 ( Pt 11):2781-6 [1658205.001]
  • [Cites] J Virol Methods. 1993 May;42(2-3):265-79 [8390474.001]
  • [Cites] Am J Clin Pathol. 1993 Jul;100(1):36-40 [8394047.001]
  • [Cites] Pathology. 1993 Apr;25(2):138-43 [8396231.001]
  • [Cites] Curr Top Microbiol Immunol. 1994;186:1-12 [8205835.001]
  • [Cites] J Oral Pathol Med. 1994 May;23(5):220-5 [8046660.001]
  • [Cites] Int J Cancer. 1995 May 16;61(4):450-4 [7759149.001]
  • [Cites] Diagn Mol Pathol. 1995 Jun;4(2):122-7 [7551292.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 Jan;32B(1):55-62 [8729620.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 Jul;32B(4):264-70 [8776424.001]
  • [Cites] Cancer Res. 1996 Oct 15;56(20):4620-4 [8840974.001]
  • [Cites] Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78 [8876633.001]
  • [Cites] Anticancer Res. 1997 Jan-Feb;17(1A):307-11 [9066669.001]
  • [Cites] Am J Pathol. 1998 Jan;152(1):145-56 [9422532.001]
  • [Cites] Oral Oncol. 1998 Sep;34(5):413-20 [9861351.001]
  • [Cites] Arch Med Res. 1999 May-Jun;30(3):255-62 [10427877.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Dec;98(6):705-11 [15583544.001]
  • [Cites] Int J Cancer. 2005 Mar 1;113(6):946-50 [15514945.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75 [15734974.001]
  • [Cites] Infect Dis Obstet Gynecol. 2004 Jun;12(2):45-56 [15739817.001]
  • [Cites] J Clin Virol. 2005 Mar;32 Suppl 1:S59-66 [15753013.001]
  • [Cites] Acta Otolaryngol. 2005 Aug;125(8):888-93 [16158538.001]
  • [Cites] Oral Dis. 2005 Nov;11(6):350-9 [16269025.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2005;67(4):237-41 [16276120.001]
  • [Cites] Arch Pathol Lab Med. 2006 Jan;130(1):57-61 [16390239.001]
  • [Cites] Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):701-9 [16467079.001]
  • [Cites] Mol Diagn Ther. 2006;10(1):49-55 [16646577.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):104-6 [16324781.001]
  • [Cites] J Oral Pathol Med. 2006 Jul;35(6):338-44 [16762014.001]
  • [Cites] Braz J Otorhinolaryngol. 2006 Mar-Apr;72(2):272-82 [16951865.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14152-7 [16959885.001]
  • [Cites] Int J Cancer. 2006 Dec 15;119(12):2840-50 [16998793.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Jan;65(1):46-9 [17174763.001]
  • [Cites] J Dent Res. 2007 Feb;86(2):104-14 [17251508.001]
  • [Cites] Eur J Cancer. 2007 Jan;43(2):415-32 [17079134.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Feb;36(2):153-8 [17110084.001]
  • [Cites] Anticancer Res. 2007 Jan-Feb;27(1A):283-8 [17352245.001]
  • [Cites] Laryngorhinootologie. 2007 Jul;86(7):515-9 [17286242.001]
  • [Cites] J Oral Pathol Med. 2007 Sep;36(8):482-7 [17686007.001]
  • [Cites] Nat Clin Pract Oncol. 2008 Jan;5(1):24-31 [18097454.001]
  • [Cites] Euro Surveill. 2009 Feb 12;14(6). pii: 19119 [19215721.001]
  • [Cites] Auris Nasus Larynx. 2009 Apr;36(2):232-4 [18621496.001]
  • [Cites] Pharmacoeconomics. 2009;27(2):127-47 [19254046.001]
  • [Cites] Oncology. 2009;76(3):205-8 [19209011.001]
  • [Cites] S D Med. 2008 Dec;61(12):453, 455 [19266896.001]
  • [Cites] PLoS One. 2009;4(3):e4941 [19293934.001]
  • [Cites] Cancer. 2009 Apr 15;115(8):1660-8 [19197996.001]
  • [Cites] Commun Dis Intell Q Rep. 2008 Dec;32(4):371-87 [19374268.001]
  • [Cites] Head Neck Oncol. 2009;1:8 [19331691.001]
  • [Cites] Vaccine. 2009 May 26;27(25-26):3391-4 [19200838.001]
  • [Cites] J Clin Pathol. 2002 Apr;55(4):244-65 [11919208.001]
  • [Cites] Nat Rev Cancer. 2002 May;2(5):342-50 [12044010.001]
  • [Cites] Oral Oncol. 2002 Jul;38(5):491-9 [12110345.001]
  • (PMID = 19555477.001).
  • [ISSN] 1758-3284
  • [Journal-full-title] Head & neck oncology
  • [ISO-abbreviation] Head Neck Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Papillomavirus Vaccines
  • [Other-IDs] NLM/ PMC2706235
  • [General-notes] NLM/ Original DateCompleted: 20100629
  •  go-up   go-down


23. Dackour R, Carter T, Steinberg BM: Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes. In Vitro Cell Dev Biol Anim; 2005 Mar-Apr;41(3-4):111-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infection of laryngeal epithelial cells by human papillomaviruses causes recurrent respiratory papillomas, benign tumors characterized by an altered pattern of differentiation.
  • Papilloma cells overexpress the EGFR and have constitutively active extracellular signal-regulated kinase (ERK) and enhanced phosphatidylinositol 3-kinase (PI3K) activity, but overexpression of the lipid phosphatase PTEN (Phosphatase and Tensin Homolog) reduces activation of Akt by PI3K.
  • We conclude that PI3K activation is an important regulator of expression of K13, a marker for the normal differentiation process in human mucosal keratinocytes, that this function does not require activation of Akt-1, and that the failure to express K13 in papilloma cells is not because of reduction in activated Akt.
  • [MeSH-major] Keratinocytes / cytology. Larynx / cytology. Phosphatidylinositol 3-Kinases / metabolism
  • [MeSH-minor] Cell Differentiation. Chromones / pharmacology. Enzyme Inhibitors / pharmacology. Humans. Laryngeal Neoplasms. Morpholines / pharmacology. Papilloma. Protein Sorting Signals / physiology. RNA, Small Interfering. Tumor Cells, Cultured

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1999 Dec 24;274(52):37285-91 [10601294.001]
  • [Cites] EMBO J. 1996 Dec 2;15(23):6541-51 [8978681.001]
  • [Cites] J Biol Chem. 1992 Feb 5;267(4):2600-4 [1733958.001]
  • [Cites] J Biol Chem. 1996 Mar 15;271(11):6245-51 [8626417.001]
  • [Cites] J Dermatol Sci. 1998 Jul;17(3):167-81 [9697045.001]
  • [Cites] Biochim Biophys Acta. 2002 Oct 10;1584(2-3):73-80 [12385889.001]
  • [Cites] Otolaryngol Head Neck Surg. 1982 Nov-Dec;90(6):728-35 [10994421.001]
  • [Cites] Cancer Res. 1993 Feb 15;53(4):910-4 [7679053.001]
  • [Cites] Biotechniques. 1993 May;14(5):752-3 [7685610.001]
  • [Cites] J Cell Sci. 1990 May;96 ( Pt 1):115-9 [2373737.001]
  • [Cites] Biochem J. 2000 Mar 15;346 Pt 3:561-76 [10698680.001]
  • [Cites] J Virol. 2002 Feb;76(3):1533-6 [11773428.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Nov 10;95(23 ):13513-8 [9811831.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1990 Oct;116(10):1167-71 [1698389.001]
  • [Cites] Cancer Res. 1988 Sep 1;48(17):4827-33 [3409223.001]
  • [Cites] Trends Biochem Sci. 1996 May;21(5):178-81 [8871402.001]
  • [Cites] Nature. 2001 May 24;411(6836):494-8 [11373684.001]
  • [Cites] J Biol Chem. 2003 Mar 28;278(13):11528-35 [12547824.001]
  • [Cites] Curr Opin Cell Biol. 2001 Oct;13(5):555-62 [11544023.001]
  • [Cites] Oncogene. 1999 Dec 23;18(56):8024-32 [10637513.001]
  • [Cites] Cancer Res. 1999 Feb 15;59(4):968-74 [10029092.001]
  • [Cites] Cancer Res. 2003 Jan 15;63(2):319-23 [12543782.001]
  • [Cites] J Gen Virol. 2002 Jul;83(Pt 7):1651-8 [12075083.001]
  • [Cites] Exp Cell Res. 2004 Apr 1;294(2):356-65 [15023526.001]
  • [Cites] Science. 1999 Apr 9;284(5412):313-6 [10195895.001]
  • [Cites] Oncogene. 2002 Jan 10;21(2):207-16 [11803464.001]
  • [Cites] J Clin Invest. 2001 Aug;108(4):527-36 [11518726.001]
  • [Cites] Anal Biochem. 1979 Jul 15;96(2):263-78 [89822.001]
  • [Cites] Cell. 1980 Apr;19(4):1033-42 [6155214.001]
  • [Cites] Cancer Res. 2000 Mar 1;60(5):1457-62 [10728713.001]
  • [Cites] J Cell Biol. 1981 Sep;90(3):732-7 [6895225.001]
  • [Cites] Mol Biol Cell. 2002 Aug;13(8):2946-62 [12181358.001]
  • [Cites] EMBO J. 2000 Jun 1;19(11):2393-8 [10835338.001]
  • [Cites] J Cell Physiol. 1990 Aug;144(2):326-32 [1696274.001]
  • [Cites] J Invest Dermatol. 1997 Dec;109(6):751-6 [9406816.001]
  • [Cites] J Invest Dermatol. 2002 Feb;118(2):303-9 [11841548.001]
  • [Cites] Cell. 1975 Nov;6(3):331-43 [1052771.001]
  • [Cites] Exp Dermatol. 2000 Jun;9(3):192-9 [10839717.001]
  • [Cites] Nat Cell Biol. 2002 Jul;4(7):509-13 [12080346.001]
  • [Cites] Science. 1999 Apr 9;284(5412):316-20 [10195896.001]
  • [Cites] Laryngoscope. 1987 Jun;97(6):678-85 [3035299.001]
  • [Cites] Mol Med. 2003 Mar-Apr;9(3-4):77-84 [12865943.001]
  • [Cites] FEBS Lett. 2000 Nov 10;484(3):217-23 [11078882.001]
  • [Cites] Curr Biol. 1997 Apr 1;7(4):261-9 [9094314.001]
  • [Cites] Exp Cell Res. 1999 Nov 25;253(1):100-9 [10579915.001]
  • [Cites] J Biol Chem. 2002 Oct 25;277(43):40390-6 [12183446.001]
  • [Cites] Cell. 1982 Nov;31(1):11-24 [6186379.001]
  • [Cites] Science. 2002 May 31;296(5573):1655-7 [12040186.001]
  • [Cites] J Invest Dermatol. 1983 Jul;81(1 Suppl):95s-100s [6134777.001]
  • [Cites] J Virol. 1982 Oct;44(1):393-400 [6292500.001]
  • [Cites] FEBS Lett. 2003 Jul 3;546(1):93-7 [12829242.001]
  • [Cites] Annu Rev Biochem. 1979;48:193-216 [382984.001]
  • (PMID = 16029072.001).
  • [ISSN] 1071-2690
  • [Journal-full-title] In vitro cellular & developmental biology. Animal
  • [ISO-abbreviation] In Vitro Cell. Dev. Biol. Anim.
  • [Language] eng
  • [Grant] United States / NIDCD NIH HHS / DC / P50 DC00203
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Chromones; 0 / Enzyme Inhibitors; 0 / Morpholines; 0 / Protein Sorting Signals; 0 / RNA, Small Interfering; 31M2U1DVID / 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; EC 2.7.1.- / Phosphatidylinositol 3-Kinases
  •  go-up   go-down


24. Shehab N, Sweet BV, Hogikyan ND: Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy; 2005 Jul;25(7):977-89
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The disease, which occurs in both juvenile and adult forms, is characterized by benign epithelial tumors of the airway that most frequently affect the larynx but can also spread along the entire aerodigestive tract.
  • Recurrent respiratory papillomatosis is the most common benign neoplasm of the larynx in children and the second most frequent cause of childhood hoarseness.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Cytosine / analogs & derivatives. Neoplasm Recurrence, Local / drug therapy. Organophosphonates / therapeutic use. Papilloma / drug therapy. Respiratory Tract Neoplasms / drug therapy


25. Mammas IN, Sourvinos G, Vakonaki E, Giamarelou P, Michael C, Spandidos DA: Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis. Eur J Pediatr; 2010 Aug;169(8):1017-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis.
  • INTRODUCTION: Recurrent respiratory papillomatosis (RRP) is characterized by the presence of benign virally induced tumors of the larynx and respiratory epithelium that may obstruct the airway and tend to recur frequently.
  • RRP is caused by the human papilloma virus (HPV), most frequently by HPV types 6 and 11.

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • MedlinePlus Health Information. consumer health - HPV.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Pediatr. 2009 Mar;168(3):267-73 [19050916.001]
  • [Cites] J Laryngol Otol. 1994 Mar;108(3):226-9 [8169504.001]
  • [Cites] J Med Virol. 1999 Sep;59(1):110-6 [10440817.001]
  • [Cites] Laryngoscope. 1997 Jul;107(7):915-8 [9217130.001]
  • [Cites] Expert Opin Pharmacother. 2009 Mar;10(4):645-55 [19284366.001]
  • [Cites] Laryngoscope. 1997 Jul;107(7):942-7 [9217136.001]
  • [Cites] J Clin Virol. 2007 Nov;40(3):252-4 [17897873.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2006 Jan;115(1):1-11 [16466093.001]
  • [Cites] BMJ. 2007 Aug 25;335(7616):375-7 [17717366.001]
  • [Cites] Pediatr Dev Pathol. 2008 Mar-Apr;11(2):118-21 [17990904.001]
  • [Cites] Arch Dis Child. 2006 Aug;91(8):689-91 [16861486.001]
  • [Cites] N Engl J Med. 2003 Feb 6;348(6):518-27 [12571259.001]
  • [Cites] Otolaryngol Head Neck Surg. 1999 May;120(5):698-705 [10229596.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):711-5 [16847177.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2009 May;73(5):681-4 [19193450.001]
  • [Cites] Pediatr Infect Dis J. 2008 Feb;27(2):149-54 [18174855.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Dec;11(6):433-41 [14631175.001]
  • [Cites] Head Neck. 1998 May;20(3):250-65 [9570632.001]
  • [Cites] Nat Rev Cancer. 2002 May;2(5):342-50 [12044010.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Mar;120(3):277-82 [8123236.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2008 Jul;265 Suppl 1:S89-96 [18193443.001]
  • [Cites] Diagn Mol Pathol. 2005 Dec;14(4):230-6 [16319693.001]
  • [Cites] Cancer Detect Prev. 2007;31(4):276-81 [17935912.001]
  • [Cites] Clin Infect Dis. 2007 Sep 1;45(5):609-7 [17682997.001]
  • [Cites] Vaccine. 2008 Aug 18;26(35):4513-8 [18598734.001]
  • [Cites] Obstet Gynecol. 1986 Dec;68(6):795-9 [3785792.001]
  • [Cites] Laryngoscope. 2004 Nov;114(11 Pt 2 Suppl 104):1-23 [15514560.001]
  • [Cites] Acta Otolaryngol. 2005 Aug;125(8):888-93 [16158538.001]
  • (PMID = 20213305.001).
  • [ISSN] 1432-1076
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] EC 3.1.21.- / DNA Restriction Enzymes; Recurrent respiratory papillomatosis
  •  go-up   go-down


26. Nowaczewska K, Wójtowicz P, Kukwa A, Ratajczak J, Tulibacki M: [Respiratory papillomatosis--new methods of treatment]. Otolaryngol Pol; 2010 Jan-Feb;64(1):31-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common location in head and neck is larynx, palatine tonsils and arches of palate, uvula and mucosa oral and nasal cavity.
  • The disease is benign but recurrent.
  • The treatment was based on surgical excision of papilloma and after it intralesional injection of cidofovir in after 4-5 weeks.
  • 18 patients had increased number of injection of ciodofovir because of recurrent papilloma.
  • CONCLUSION: Surgery with intralesional cidofovir injection in the place after removal of papilloma is very effective methods.
  • We observed that this treatment caused long lasting remission of papilloma recurrence.
  • [MeSH-major] Antiviral Agents / administration & dosage. Cytosine / analogs & derivatives. Laryngeal Neoplasms / drug therapy. Organophosphonates / administration & dosage. Papilloma / drug therapy

  • Hazardous Substances Data Bank. CIDOFOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20476590.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Organophosphonates; 8J337D1HZY / Cytosine; JIL713Q00N / cidofovir
  •  go-up   go-down


27. Ulualp SO, Ryan MW, Wright ST: Microdebrider removal of tracheal papilloma via tracheostomy in the child with an obliterated larynx. J Laryngol Otol; 2007 Nov;121(11):1070-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microdebrider removal of tracheal papilloma via tracheostomy in the child with an obliterated larynx.
  • In children, recurrent respiratory papillomatosis is the most common benign neoplasm of the airway.
  • The disease frequently involves the larynx and may spread to extralaryngeal sites.
  • We describe a technique for using a microdebrider to remove tracheal papillomas when the larynx is obliterated with the disease.
  • [MeSH-major] Debridement / methods. Neoplasm Recurrence, Local / surgery. Papilloma / surgery. Tracheal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17419899.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


28. Peschos D, Damala C, Stefanou D, Tsanou E, Assimakopoulos D, Vougiouklakis T, Charalabopoulos K, Agnantis NJ: Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions. Histol Histopathol; 2006 06;21(6):603-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
  • With the present study, we tried to demonstrate the expression of MMP-9 immunohistochemically, comparatively in benign, premalignant and malignant lesions of the larynx.
  • [MeSH-major] Laryngeal Neoplasms / chemistry. Larynx / chemistry. Matrix Metalloproteinase 9 / analysis. Precancerous Conditions / chemistry
  • [MeSH-minor] Carcinoma in Situ / chemistry. Carcinoma in Situ / metabolism. Carcinoma in Situ / pathology. Carcinoma, Squamous Cell / chemistry. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / pathology. Disease Progression. Female. Humans. Immunohistochemistry. Keratosis / metabolism. Keratosis / pathology. Laryngeal Diseases / metabolism. Laryngeal Diseases / pathology. Male. Middle Aged. Neoplasm Invasiveness / pathology. Papilloma / chemistry. Papilloma / metabolism. Papilloma / pathology. Up-Regulation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16528670.001).
  • [ISSN] 1699-5848
  • [Journal-full-title] Histology and histopathology
  • [ISO-abbreviation] Histol. Histopathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


29. McKenna M, Brodsky L: Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol; 2005 May;69(5):597-605
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraesophageal acid reflux and recurrent respiratory papilloma in children.
  • OBJECTIVE: Recurrent respiratory papillomatosis (RRP) is a benign infectious disease which is caused by the human papilloma virus (HPV).
  • When it infects the larynx, hoarseness and airway obstruction are often the presenting symptoms.
  • Lapses in compliance with medications or behavioral and dietary recommendations in three out of four patients led to a rebound in symptoms and signs of RRP, including worsening of vocal quality and the endoscopic appearance of the larynx.
  • [MeSH-major] Gastroesophageal Reflux / complications. Gastroesophageal Reflux / diagnosis. Laryngeal Neoplasms / complications. Neoplasm Recurrence, Local / complications. Papilloma / complications

  • MedlinePlus Health Information. consumer health - GERD.
  • MedlinePlus Health Information. consumer health - Reflux in Children.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Pediatr Otorhinolaryngol. 2006 Apr;70(4):757-8; author reply 759 [16242786.001]
  • (PMID = 15850681.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


30. Cao Z, Gu Z, Yang J, Jin M: Respiratory epithelial adenomatoid hamartoma of bilateral olfactory clefts associated with nasal polyposis: three cases report and literature review. Auris Nasus Larynx; 2010 Jun;37(3):352-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although REAH is benign lesion it can probably continue developing after operation if REAH was not completely resected.
  • Although REAH arising from the rhinosinusal region is very rare, rhinolaryngologists should know this entity thoroughly in order to differentiate it from inverted papilloma and adenocarcinoma, since misinterpretation of this lesion may result in aggressive surgery for a benign lesion which could greatly affect patient's quality of life after operation.

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19942387.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 12
  •  go-up   go-down


31. Pudszuhn A, Welzel C, Bloching M, Neumann K: Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol; 2007 Jan;264(1):63-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent laryngeal papillomatosis is a benign disease of the larynx often leading to organic and functional restrictions.
  • The therapeutic treatment of choice in larynx-obstructing papillomatosis is at present surgical laser ablation.
  • After 2-7 treatments with surgical laser papilloma ablation and intralesional Cidofovir injections, all patients showed a definite papilloma reduction, while in six cases complete remission was achieved.
  • [MeSH-major] Antiviral Agents / therapeutic use. Cytosine / analogs & derivatives. Laryngeal Neoplasms / drug therapy. Laryngeal Neoplasms / pathology. Organophosphonates / therapeutic use. Papilloma / drug therapy. Papilloma / pathology

  • Genetic Alliance. consumer health - Laryngeal papillomatosis.
  • Hazardous Substances Data Bank. CIDOFOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Otol Rhinol Laryngol. 2003 Apr;112(4):298-302 [12731623.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):841-6 [12925342.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2002 Nov;259(10):516-20 [12434183.001]
  • [Cites] J Med Virol. 1998 Mar;54(3):219-25 [9515772.001]
  • [Cites] Laryngoscope. 2003 Sep;113(9):1583-7 [12972938.001]
  • [Cites] Ear Nose Throat J. 2000 Apr;79(4):236-8, 240 [10786384.001]
  • [Cites] Drugs. 1996 Aug;52(2):225-230; discussion 231 [8841740.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 Oct;125(10):1143-8 [10522508.001]
  • [Cites] Laryngoscope. 2003 Dec;113(12):2174-81 [14660923.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 Jul;125(7):743-8 [10406310.001]
  • [Cites] Otolaryngol Head Neck Surg. 1999 May;120(5):698-705 [10229596.001]
  • [Cites] J Med Virol. 1995 Feb;45(2):230-5 [7775945.001]
  • [Cites] Verh K Acad Geneeskd Belg. 2001;63(2):93-120, discussion 120-2 [11436421.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Dec;11(6):433-41 [14631175.001]
  • [Cites] Laryngoscope. 2001 Jan;111(1):57-69 [11192901.001]
  • [Cites] Otolaryngol Clin North Am. 2000 Oct;33(5):1127-42 [10984775.001]
  • [Cites] Arch Pathol Lab Med. 2002 Oct;126(10):1184-8 [12296755.001]
  • [Cites] Semin Cancer Biol. 1999 Dec;9(6):379-86 [10712884.001]
  • [Cites] Otolaryngol Head Neck Surg. 1995 Feb;112(2):197-202 [7530830.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1999;256(9):450-4 [10552224.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2000 Oct;126(10):1239-43 [11031411.001]
  • [Cites] Laryngoscope. 2004 Jul;114(7):1151-6 [15235339.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2004 Apr;68(4):413-8 [15013606.001]
  • [Cites] Chest. 2000 Oct;118(4):1210-4 [11035700.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Oct;129(10):1081-5 [14568791.001]
  • [Cites] Pediatr Infect Dis J. 1998 May;17(5):372-6 [9613648.001]
  • [Cites] Laryngorhinootologie. 2003 Oct;82(10):700-6 [14593568.001]
  • [Cites] Laryngoscope. 1998 Jun;108(6):935-7 [9628513.001]
  • [Cites] Laryngoscope. 2002 Apr;112(4):696-9 [12150526.001]
  • (PMID = 17058091.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Organophosphonates; 8J337D1HZY / Cytosine; JIL713Q00N / cidofovir
  •  go-up   go-down






Advertisement